Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Philipps-Universitaet Marburg
Sponsor

Philipps-Universitaet Marburg

Germany Karl-Von-Frisch-Strasse 4, 35043 Marburg, Germany

About the sponsor

Research activity includes pulmonary arterial hypertension, with attention to right ventricular diastolic function and treatment effects on cardiac performance.

  • Right ventricular function
  • Pulmonary arterial hypertension
  • Cardiopulmonary remodeling

The sponsor also supports work on therapies aimed at improving functional outcomes in advanced pulmonary vascular disease.

About Specializations

Philipps-Universitaet Marburg runs clinical trials in conditions such as Idiopathic pulmonary fibrosis, Chronic spontaneous urticaria, Small intestine neuroendocrine tumour, Bronchiectasis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Chronic spontaneous urticaria

Recruiting

Study of tildrakizumab to treat patients with chronic spontaneous urticaria who did not respond to previous treatments

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tildrakizumab
  • Sponsor:Philipps-Universitaet Marburg

Small intestine neuroendocrine tumour

Recruiting

Efficacy of 177Lu-DOTATATE as Adjuvant Therapy After Surgery for Stage III Small Intestinal Neuroendocrine Tumors

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) oxodotreotide
  • Sponsor:Philipps-Universitaet Marburg

Bronchiectasis

Recruiting

Study on Inhaled Colistimethate Sodium for Adults with Bronchiectasis and New Asymptomatic Pseudomonas Aeruginosa Infection

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colistimethate Sodium
  • Sponsor:Philipps-Universitaet Marburg

Adrenogenital syndrome

Recruiting

Study on the Effectiveness of Dexamethasone in Preventing Prenatal Virilization in Female Patients with Congenital Adrenal Hyperplasia

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Dexamethasone
  • Sponsor:Philipps-Universitaet Marburg

Idiopathic pulmonary fibrosis

Not yet recruiting

Safety and Tolerability of Metformin in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Placebo‑Controlled Phase II Study

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Philipps-Universitaet Marburg

Pulmonary arterial hypertension

Not yet recruiting

Study of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Philipps-Universitaet Marburg

Interstitial lung disease+1

Not yet recruiting

Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:Philipps-Universitaet Marburg

Idiopathic pulmonary fibrosis

Not yet recruiting

Study on Inhaled Phospholipid Fraction from Bovine Lung for Patients with Idiopathic Pulmonary Fibrosis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Phospholipid Fraction, Bovine Lung
  • Sponsor:Philipps-Universitaet Marburg

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.